141 related articles for article (PubMed ID: 8396909)
1. Photoaffinity labelling of cyclic GMP-binding proteins in human platelets.
Tang KM; Sherwood JL; Haslam RJ
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):329-33. PubMed ID: 8396909
[TBL] [Abstract][Full Text] [Related]
2. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors.
Tang KM; Jang EK; Haslam RJ
Eur J Pharmacol; 1994 Jun; 268(1):105-14. PubMed ID: 7925608
[TBL] [Abstract][Full Text] [Related]
3. Intact cell and cell-free phosphorylation and concomitant activation of a low Km, cAMP phosphodiesterase found in human platelets.
Macphee CH; Reifsnyder DH; Moore TA; Beavo JA
J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):487-96. PubMed ID: 2831258
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP-binding proteins in human blood platelets detected by photoaffinity labelling.
Chambers DA; Nachman RL; Evarts J; Kinoshita T
Biochim Biophys Acta; 1982 Nov; 719(2):208-14. PubMed ID: 6295503
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic and sarcoplasmic reticulum-associated low Km, cGMP-inhibited cAMP phosphodiesterase in mammalian myocardium.
Smith CJ; Krall J; Manganiello VC; Movsesian MA
Biochem Biophys Res Commun; 1993 Jan; 190(2):516-21. PubMed ID: 8381278
[TBL] [Abstract][Full Text] [Related]
6. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation.
Degerman E; Smith CJ; Tornqvist H; Vasta V; Belfrage P; Manganiello VC
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):533-7. PubMed ID: 2153956
[TBL] [Abstract][Full Text] [Related]
7. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.
Tremblay J; Lachance B; Hamet P
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):397-411. PubMed ID: 2411769
[TBL] [Abstract][Full Text] [Related]
8. Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase.
Degerman E; Moos M; Rascón A; Vasta V; Meacci E; Smith CJ; Lindgren S; Andersson KE; Belfrage P; Manganiello V
Biochim Biophys Acta; 1994 Apr; 1205(2):189-98. PubMed ID: 8155697
[TBL] [Abstract][Full Text] [Related]
9. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-reactive proteins in human saliva.
Mednieks MI; Epstein PM; Hachisu R; Hand AR; Esquire RG
Arch Oral Biol; 1994 Oct; 39(10):869-75. PubMed ID: 7741656
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
Manns JM; Brenna KJ; Colman RW; Sheth SB
Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
[TBL] [Abstract][Full Text] [Related]
12. Identification of cGMP-dependent protein kinase and its specific substrates in the anterior pituitary.
Li H; Liu JP; Smith R; Robinson PJ
Mol Cell Endocrinol; 1996 Sep; 122(2):159-71. PubMed ID: 8902846
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells.
Sandberg M; Butt E; Nolte C; Fischer L; Halbrügge M; Beltman J; Jahnsen T; Genieser HG; Jastorff B; Walter U
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):521-7. PubMed ID: 1659381
[TBL] [Abstract][Full Text] [Related]
14. Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets.
Seiler S; Gillespie E; Arnold AJ; Brassard CL; Meanwell NA; Fleming JS
Thromb Res; 1991 Apr; 62(1-2):31-42. PubMed ID: 1649498
[TBL] [Abstract][Full Text] [Related]
15. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
[TBL] [Abstract][Full Text] [Related]
16. Expression and mutagenesis of the catalytic domain of cGMP-inhibited phosphodiesterase (PDE3) cloned from human platelets.
Tang KM; Jang EK; Haslam RJ
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):217-24. PubMed ID: 9173884
[TBL] [Abstract][Full Text] [Related]
17. Second messenger-specific protein kinases in a salt-absorbing intestinal epithelium.
Toskulkao C; Nash NT; Leach K; Rao MC
Am J Physiol; 1990 May; 258(5 Pt 1):C879-88. PubMed ID: 2159231
[TBL] [Abstract][Full Text] [Related]
18. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases.
Waldmann R; Nieberding M; Walter U
Eur J Biochem; 1987 Sep; 167(3):441-8. PubMed ID: 2820726
[TBL] [Abstract][Full Text] [Related]
19. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport.
Borgognone A; Pulcinelli FM
Thromb Haemost; 2012 Nov; 108(5):955-62. PubMed ID: 23014861
[TBL] [Abstract][Full Text] [Related]
20. Two isoforms of cGMP-inhibited cyclic nucleotide phosphodiesterases in human tissues distinguished by their responses to vesnarinone, a new cardiotonic agent.
Masuoka H; Ito M; Sugioka M; Kozeki H; Konishi T; Tanaka T; Nakano T
Biochem Biophys Res Commun; 1993 Jan; 190(2):412-7. PubMed ID: 8381275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
